|
|
| (11) | Number of the document | C 1581254 |
| (68) | Number of the document | 1581254 |
| (21) | Application number for Supplementary Protection Certificate | PA 2013 020 |
| (22) | Date of filing the application | 2013-08-23 |
| (41) | Date of publication of the application | 2013-10-25 |
| Date of publication of SPC | 2015-03-25 | |
| (24) | Date of coming into effect of SPC | 2023-12-06 |
| (71) |
ThromboGenics N.V.,
,
|
| (73) |
Oxurion NV,
Gaston Geenslaan 1, 3001 Heverlee (Leuven),
BE
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (93) | EU/1/13/819/001, 2013-03-13 |
| (94) | 2028-03-15 |
| (95) | Ocriplasminum (microplasminum) |
| SPC lapsed (non-payment of fees for the main patent) | ||
| Date of negative decision to issue the SPC | 2021-12-05 |